News

Explore insights from six leading epileptologists on the evolution of epilepsy diagnosis and treatment, highlighting innovations and future challenges from the 2024 ILAE Congress.

Epilepsy is one of the most common neurological disorders. Despite its prevalence, widespread misconceptions and social stigma continue to marginalize those living with the condition.

Gender-based violence has a profound impact on women’s mental health, often leading to anxiety, depression, and post-traumatic stress disorder (PTSD).

The United Nations launched this initiative in 2015 to promote gender equality in STEM, an opportunity to support and include women and girls in order for them to receive full and equal access to careers in science.

There are over 50 million people living with epilepsy and over 50% of them will experience some kind of stigma surrounding the illness.

Angelini Pharma has been awarded the prestigious Top Employer certification for the sixth consecutive year.

LIFE-GREENAPI: Innovating for the Future is the title of the event hosted by Angelini Pharma at its Fine Chemicals plant in Aprilia.

Rafal Kaminski contributes an op-ed to Labiotech in which he presents an overview of the current treatment landscape for people living with epilepsy.

Initiated by the European Commission and funded by the Marie Sklodowska Curie Actions (MSCA), European Researchers' Night is the largest science outreach and research event in Europe.

Jacopo Andreose advocates for increased European investment in Mental Health, highlighting its societal and economic benefits in an Op-Ed for Euroactiv.